![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bullock Roger
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.13, Iss.4, 2004-04, pp. : 303-314
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease
By Jönsson L.
PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Evaluation of memantine for the treatment of Alzheimer’s disease
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)